HBFBX Performance — Hennessy Balanced Fund, Investor Class
Data updated: 2026-09-28
HBFBX returned +8.15% year to date and +14.44% over one year to Jul 2026. Annualised returns are +8.32% over 3 years and +5.23% over 5 years. The fund trailed its Moderate Allocation category average: $100 invested three years ago grew to $127, against $138 for the category, and to $114 over one year, against $115. Volatility over the past three years was 6.18% a year. In the 12 months to Jul 2026 the fund lost a net $751K, and assets reached $13.92M.
HBFBX Growth of $100
What $100 invested in Hennessy Balanced Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Moderate Allocation category average over the same months.
| Period | HBFBX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $115 |
| 3 years (Aug 2023 – Jul 2026) | $127 | $138 |
| 5 years (Aug 2021 – Jul 2026) | $129 | $133 |
| Since data start (Aug 2019 – Jul 2026) | $137 | $168 |
HBFBX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.15% |
| 1 year | +14.44% |
| 3 years (annualised) | +8.32% |
| 5 years (annualised) | +5.23% |
HBFBX Annual Returns
Calendar-year total returns of Hennessy Balanced Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.15% |
| 2025 | +9.89% |
| 2024 | +3.23% |
| 2023 | +5.23% |
| 2022 | −1.19% |
| 2021 | +7.99% |
| 2020 | −2.97% |
| 2019 (Aug–Dec) | +2.21% |
HBFBX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.5% | +3.5% | −2.1% | −0.1% | +1.8% | +0.9% | +1.4% | — | — | — | — | — |
| 2025 | +2.5% | +2.3% | −0.2% | −2.5% | +0.8% | +1.5% | −0.5% | +1.7% | +0.5% | +1.1% | +3.1% | −0.6% |
| 2024 | +0.2% | −0.7% | +2.2% | −1.8% | +1.5% | −0.9% | +3.6% | +1.0% | +0.9% | −1.6% | +1.4% | −2.6% |
| 2023 | +1.0% | −2.2% | +1.5% | −0.4% | −2.5% | +1.9% | +2.4% | 0.0% | −1.9% | −1.0% | +3.1% | +3.5% |
| 2022 | +0.2% | −0.8% | +1.5% | −1.1% | +2.6% | −4.8% | +1.0% | −2.4% | −4.2% | +6.1% | +3.6% | −2.4% |
| 2021 | −0.3% | +2.6% | +4.2% | +0.2% | +1.5% | −0.8% | −0.7% | +0.6% | −2.2% | +1.1% | −2.3% | +4.1% |
| 2020 | −3.0% | −4.6% | −5.1% | +4.4% | +0.7% | −1.4% | +0.7% | +1.2% | −1.7% | −1.5% | +6.5% | +1.3% |
| 2019 | — | — | — | — | — | — | — | −1.8% | +1.2% | +0.3% | +1.3% | +1.2% |
HBFBX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 6.18%
- 3-year Sharpe ratio: 0.62 (vs 4.5% risk-free rate)
- Best month: +3.60% (Jul 2024)
- Worst month: −2.58% (Dec 2024)
HBFBX Fund Flows
Monthly money in and out of Hennessy Balanced Fund, from SEC Form N-PORT.
- 12-month net flow: −$751K
- 12-month gross sales (incl. reinvestments): $738K
- Sales ÷ redemptions: 0.50×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $117K | $100K | $17K |
| Jun 2026 | $56K | $243K | −$187K |
| May 2026 | $11K | $46K | −$35K |
| Apr 2026 | $119K | $21K | $98K |
| Mar 2026 | $33K | $79K | −$46K |
| Feb 2026 | $69K | $81K | −$12K |
| Jan 2026 | $89K | $133K | −$43K |
| Dec 2025 | $160K | $153K | $7K |
| Nov 2025 | $2K | $134K | −$132K |
| Oct 2025 | $62K | $18K | $45K |
| Sep 2025 | $13K | $84K | −$71K |
| Aug 2025 | $7K | $399K | −$391K |
HBFBX Assets Under Management
Net assets of Hennessy Balanced Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $13.92M |
| 2026-04-30 | $13.61M |
| 2026-01-31 | $13.47M |
| 2025-10-31 | $13.04M |
| 2025-07-31 | $13.10M |
| 2025-04-30 | $12.93M |
| 2025-01-31 | $12.40M |
| 2024-10-31 | $12.66M |
| 2024-07-31 | $12.84M |
| 2024-04-30 | $12.54M |
| 2024-01-31 | $17.30M |
| 2023-10-31 | $12.29M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.